ArticleFrontiers in oncology2026

Single-cell transcriptomics reveals cellular heterogeneity and neoadjuvant chemotherapy response signatures in triple-negative breast cancer.

Menglong Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.